American depositary receipts of European stocks were trading 0.28% higher at 134.73 on the Bank of New York Mellon Europe ADR Index on Monday.
In continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS), and medical equipment company Edap (EDAP), which rose 10.7% and 1.8% respectively. They were followed by healthcare company Novo Nordisk (NVO), and biopharmaceutical company Forward Pharma (FWP), which were up 1.2% and 1%.
The decliners in continental Europe were led by CGG (CGG), a manufacturer of geophysical equipment, and biopharmaceutical firm Zealand Pharma (ZEAL), which fell 2.6% and 1.5% respectively. They were followed by VEON Com (VEON), a provider of communications services, and online hotel search platform Trivago (TRVG), which lost 1.2% and 0.7%.
In the U.K. and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP), and Verona Pharma (VRNA), which rose 4% and 0.8% respectively. They were followed by airline operator Ryanair (RYAAY), and Trinity Biotech (TRIB), which were up 0.8% each.
The decliners in the U.K. and Ireland were led by biopharmaceutical company Midatech Pharma (MTP), and construction materials supplier CRH (CRH), which fell 2.1% and 0.3% respectively. They were followed by bank Barclays (BCS), and oil company Royal Dutch Shell (RDS), each of which were down 0.1%.